Origin, a San Francisco-based construction robotics company, has emerged from stealth with $20 million in funding to scale deployment of its OG-1 robot.
Intero Biosystems, a Denver-based startup spun out of the University of Michigan, is developing lab-grown human intestinal organoids as an alternative to animal testing in drug development.